Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Current Liabilities: 2013-2018

Historic Total Current Liabilities for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $1.9 million.

  • Soleno Therapeutics' Total Current Liabilities rose 37.72% to $3.5 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.5 million, marking a year-over-year increase of 37.72%. This contributed to the annual value of $1.9 million for FY2018, which is 8.31% up from last year.
  • Soleno Therapeutics' Total Current Liabilities amounted to $1.9 million in FY2018, which was up 8.31% from $1.7 million recorded in FY2017.
  • Soleno Therapeutics' Total Current Liabilities' 5-year high stood at $3.2 million during FY2015, with a 5-year trough of $1.3 million in FY2014.
  • Its 3-year average for Total Current Liabilities is $1.8 million, with a median of $1.7 million in 2017.
  • As far as peak fluctuations go, Soleno Therapeutics' Total Current Liabilities slumped by 90.90% in 2014, and later spiked by 147.54% in 2015.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Total Current Liabilities stood at $1.3 million in 2014, then spiked by 147.54% to $3.2 million in 2015, then slumped by 46.52% to $1.7 million in 2016, then rose by 1.50% to $1.7 million in 2017, then rose by 8.31% to $1.9 million in 2018.